Bone MarrowBone Marrow CellsBone Marrow TransplantationRadiation DosageRadiation, IonizingRadiation InjuriesKidney TransplantationDose-Response Relationship, RadiationRadiation ToleranceRadiationRadiation ProtectionTransplantation, HomologousRadiation MonitoringTransplantsGraft RejectionGraft SurvivalBone Marrow DiseasesImmunosuppressive AgentsBone Marrow ExaminationTissue DonorsHematopoietic Stem CellsHeart TransplantationRadiation OncologyBone Marrow NeoplasmsTime FactorsRadiation Injuries, ExperimentalTransplantationTreatment OutcomeWhole-Body IrradiationHematopoietic Stem Cell TransplantationCosmic RadiationLung TransplantationBone Marrow PurgingGraft vs Host DiseaseCombined Modality TherapyTransplantation, AutologousRetrospective StudiesGamma RaysRadiation PneumonitisNeoplasms, Radiation-InducedHematopoiesisImmunosuppressionRadiotherapyRadiometryMice, Inbred C57BLColony-Forming Units AssayBackground RadiationCyclosporineTissue and Organ ProcurementRadiotherapy DosageHistocompatibility TestingRadiation EffectsRadiation ChimeraLeukemiaAnemia, AplasticTacrolimusPostoperative ComplicationsUltraviolet RaysRadiation-Protective AgentsLiving DonorsCells, CulturedCytomegalovirus InfectionsFollow-Up StudiesCell DifferentiationWaiting ListsSurvival AnalysisFlow CytometryRadiation-Sensitizing AgentsTransplantation ConditioningTransplantation ImmunologyHistocompatibilitySurvival RateRecurrenceFetal Tissue TransplantationTransplantation ChimeraStromal CellsAcute Radiation SyndromeSpleenImmunocompromised HostTransplantation, IsogeneicRisk FactorsMycophenolic AcidCadaverAntigens, CD34PrognosisT-LymphocytesBiopsyMice, Inbred BALB CCobalt RadioisotopesLeukemia, Myeloid, AcuteRadioactive Hazard ReleaseX-RaysCell SurvivalAcute DiseaseCyclophosphamideHematologic NeoplasmsGranulocytesKidney Failure, ChronicMultiple MyelomaProspective Studies